Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
04/30/2008 | DE202007011825U1 Pharmazeutische Dosierungsformen Pharmaceutical dosage forms |
04/30/2008 | CN101171256A Fused thiazole derivatives having affinity for the histamine h3 receptor |
04/30/2008 | CN101171253A Hydrocodone polymorphs |
04/30/2008 | CN101171238A (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor |
04/30/2008 | CN101171235A Dipyrazoles as central nervous system agents |
04/30/2008 | CN101171229A Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
04/30/2008 | CN101171228A Pregabalin free of isobutylglutaric acid and a process for preparation thereof |
04/30/2008 | CN101171227A Pregabalin free of lactam and a process for preparation thereof |
04/30/2008 | CN101171029A Agent for treating and/or preventing of neuropathic pain |
04/30/2008 | CN101171009A Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3- receptor ligands |
04/30/2008 | CN101171004A Therapeutic use of nefopam and analogues thereof |
04/30/2008 | CN101171003A Cytokine modulators using cyclic glycerides of essential poyunsaturated fatty acids |
04/30/2008 | CN101168058A Mixture preparation |
04/30/2008 | CN101168057A Dopamine agonist preparation |
04/30/2008 | CN101168056A 混合物制剂 Mixture preparation |
04/30/2008 | CN101168048A Application of cerebral tissue fluid and nerve growth factor in preparing combination medicine for treating infantile cerebral paralysis |
04/30/2008 | CN101168036A Orally-administered traditional Chinese medicinal composition for treating migraine pain |
04/30/2008 | CN101168026A Traditional Chinese medicine for treating alcohol dependence disease |
04/30/2008 | CN101168025A Medicine composition for preventing and treating senile dementia |
04/30/2008 | CN101168024A Proprietary Chinese medicine for treating depression and production method thereof |
04/30/2008 | CN101168010A Infantile heat excess wind-getting resuscitation tranquilization medicine |
04/30/2008 | CN101168009A Quality control method of macaque stone bovinebezoar powder |
04/30/2008 | CN101168007A Medicine for treating cerebral palsy diseases and its preparing process |
04/30/2008 | CN101167999A Hot compress exergy and preparation method thereof |
04/30/2008 | CN101167968A Traditional Chinese medicine for treating infantile paralytic sequelae |
04/30/2008 | CN101167965A Traditional Chinese medicinal composition for treating senile parkinsonian syndrome |
04/30/2008 | CN101167952A Donkey-hide gelatin and pine needle wine |
04/30/2008 | CN101167943A Wine capable of prolonging life |
04/30/2008 | CN101167912A Medicine for treating spastic cerebral paralysis disease and its preparing method |
04/30/2008 | CN101167905A Health product for sobering-up, alcoholism-eliminating and fatty liver prevention |
04/30/2008 | CN101167901A Chinese angelica and peony formula extraction, preparation and medical use thereof |
04/30/2008 | CN101167898A Traditional Chinese medicine preparation for treating insomnia |
04/30/2008 | CN101167873A Technology for processing honey-prepared glutinous rehmannia |
04/30/2008 | CN101167849A Traditional Chinese medicine for treating enuresis caused by fright suddenly |
04/30/2008 | CN101167836A Medicinal liquor for treating sciatica |
04/30/2008 | CN101167817A Traditional Chinese medicine for treating migraine |
04/30/2008 | CN101167814A Traditional Chinese medicine for treating kidney yin deficiency and deficiency of both yin and yang and preparation method |
04/30/2008 | CN101167803A Fresh schisandra chinensis extract and its preparation and application |
04/30/2008 | CN101167786A Process of extracting total flavone from fordia cauliflora Hemsl |
04/30/2008 | CN101167697A Donepezils compound long-acting slow-releasing and controlled-releasing composition and preparation method thereof |
04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
04/30/2008 | CN100384986C Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
04/30/2008 | CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use |
04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
04/30/2008 | CN100384850C Galantamine derivative and its preparation process and use |
04/30/2008 | CN100384849C Quinoline 3-amino chroman derivatives |
04/30/2008 | CN100384847C Adenosine a2a receptor antagonists |
04/30/2008 | CN100384843C CGRP receptor antagonists |
04/30/2008 | CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
04/30/2008 | CN100384836C Novel cyclic amide derivatives |
04/30/2008 | CN100384833C Therapeutic chroman compounds |
04/30/2008 | CN100384825C Benzheterocyclic derivatives |
04/30/2008 | CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes |
04/30/2008 | CN100384822C 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
04/30/2008 | CN100384820C Phosphate prodrugs of fluorooxindoles |
04/30/2008 | CN100384477C Complex of modafinil and cyclodextrin |
04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
04/30/2008 | CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
04/30/2008 | CN100384411C Oral carbidopa/levodopa disintegrant tablet |
04/30/2008 | CN100384410C Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
04/29/2008 | USRE40278 Heterocyclic amines having central nervous system activity |
04/29/2008 | US7365216 Process for the production of citalopram |
04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
04/29/2008 | US7365155 Immunoregulator |
04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
04/29/2008 | US7365049 Afamin-containing compositions and methods of use |
04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
04/24/2008 | WO2008049073A2 Compositions for the treatment of inflammation in the brain and other tissues |
04/24/2008 | WO2008049058A2 Cln2 treatment of alzheimer's disease |
04/24/2008 | WO2008048670A2 Compositions and methods for modulating tlr14 activity |
04/24/2008 | WO2008048648A2 Cb1-modulating compounds and their use |
04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
04/24/2008 | WO2008048503A2 Imidazole substitured pyrazole kinase inhibitors |
04/24/2008 | WO2008048194A1 Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder |
04/24/2008 | WO2008048171A1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
04/24/2008 | WO2008047952A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
04/24/2008 | WO2008047951A2 An alzheimer' s disease progression inhibitor containing heterocyclic compound |
04/24/2008 | WO2008047883A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
04/24/2008 | WO2008047167A1 Polymorphs of o-desmethyl venlafaxine succinate |
04/24/2008 | WO2008046919A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |